Alwaleed Aljohar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alwaleed Aljohar has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
Zachary Laksman
SportsCardiologyBC, The University of British Columbia Hospital, Vancouver, British Columbia, Canada; Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
2 shared publications- Abdelfatah Elasfar
Department of Adult Cardiology, Prince Salman Heart Center, King Fahad Medical City, Riyadh, Saudi Arabia
1 shared publication Abdelmaksoud Elganady
Department of Cardiology, Dr. Erfan and Bagedo General Hospital, Jeddah, Kingdom of Saudi Arabia
1 shared publicationAbdulaziz Alasmari
Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia
1 shared publicationAbdullah Al Khushail
Department of Cardiology, Prince Sultan Cardiac Center, Riyadh, Kingdom of Saudi Arabia
1 shared publicationAbdullah Ghabashi
Adult Cardiology Department, Prince Sultan Cardiac Center, Hafouf, Saudi ArabiaeSaudi Arabia
1 shared publication
Latest Publications
- Open Access
- 15 July 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (28) , 108681
Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes
- 15 July 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (28) , 108681
Open AccessArrhythmogenic Right Ventricular Cardiomyopathy in Athletes
- 1 October 2022
- Published by Elsevier in Current Problems in Cardiology
- Vol. 47 (10) , 101002
Percutaneous Coronary Intervention Vs Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Disease: G-LM Registry
- 1 October 2022
- Published by Elsevier in Current Problems in Cardiology
- Vol. 47 (10) , 101002
Percutaneous Coronary Intervention Vs Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Disease: G-LM Registry
- Open Access
- 12 June 2018
- Published by Saudi Heart Association in Journal of the Saudi Heart Association
- Vol. 30 (4) , 319-327
The prognostic impact of hyperglycemia on clinical outcomes of acute heart failure: Insights from the heart function assessment registry trial in Saudi Arabia
Background: The prognostic impact of hyperglycemia (HG) in acute heart failure (AHF) is controversial. Our aim is to examine the impact of HG on short- and long-term survival in AHF patients. Methods: Data from the Heart Function Assessment Registry Trial in Saudi Arabia (HEARTS) for patients who had available random blood sugar (RBS) were analyzed. The enrollment period was from October 2009 to December 2010. Comparisons were performed according to the RBS levels on admission as either p = 0.003, 10.4% vs. 7.2%; p = 0.007, and 21.8% vs. 18.4%; p = 0.04, respectively). There were no differences between the two groups in 2- or 3-year mortality rates. After adjustment for relevant confounders, HG remained an independent predictor for hospital and 30-day mortality [odds ratio (OR) = 1.6; 95% confidence interval (CI) 1.07–2.42; p = 0.021, and OR = 1.55; 95% CI 1.07–2.25; p = 0.02, respectively]. Conclusion: HG on admission is independently associated with hospital and short-term mortality in AHF patients. Future research should focus on examining the impact of tight glycemic control on outcomes of AHF patients.
- 12 June 2018
- Published by Saudi Heart Association in Journal of the Saudi Heart Association
- Vol. 30 (4) , 319-327
Open AccessThe prognostic impact of hyperglycemia on clinical outcomes of acute heart failure: Insights from the heart function assessment registry trial in Saudi Arabia
Background: The prognostic impact of hyperglycemia (HG) in acute heart failure (AHF) is controversial. Our aim is to examine the impact of HG on short- and long-term survival in AHF patients. Methods: Data from the Heart Function Assessment Registry Trial in Saudi Arabia (HEARTS) for patients who had available random blood sugar (RBS) were analyzed. The enrollment period was from October 2009 to December 2010. Comparisons were performed according to the RBS levels on admission as either p = 0.003, 10.4% vs. 7.2%; p = 0.007, and 21.8% vs. 18.4%; p = 0.04, respectively). There were no differences between the two groups in 2- or 3-year mortality rates. After adjustment for relevant confounders, HG remained an independent predictor for hospital and 30-day mortality [odds ratio (OR) = 1.6; 95% confidence interval (CI) 1.07–2.42; p = 0.021, and OR = 1.55; 95% CI 1.07–2.25; p = 0.02, respectively]. Conclusion: HG on admission is independently associated with hospital and short-term mortality in AHF patients. Future research should focus on examining the impact of tight glycemic control on outcomes of AHF patients.